Avatar

CAR T and NK Cell Therapy in Myeloma

By Parameswaran Hari 5 Videos
08/2018
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Association of Northern California Oncologists

ASCO Highlights 2019

Sat, Aug 17, 2019
07:23
Indy Hematology Review

Novel Immune Therapies in Myeloma: BCMA Immunotoxin, Bites, and CAR T cells

Feat. K. Anderson
15:02
Krina Patel

Clinical Trials in Myeloma in 2018

15:47
Society of Hematologic Oncology Sixth Annual Meeting

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
12:32
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:10
Krina Patel

Developing CAR T-cells in Multiple Myeloma

13:30
Helen Heslop

CAR T-cell Therapy for Hematologic Malignancies Other Than CD19

09:46
2018 Pan Pacific Lymphoma Conference

CAR T-cell Toxicities and Team Management

Feat. S. Blumel
10:37
Krina Patel

How Do We Make Responses Durable in Multiple Myeloma?

14:42
Society of Hematologic Oncology Sixth Annual Meeting

What Will The Future Hold for Myeloma Treatment CARTs vs BiTES?

Feat. R. Orlowski
16:59
Nina Shah

The Future of CAR T Therapies in Myeloma in 2018

03:33
Krina Patel

The Future in Multiple Myeloma: BiTE, CAR T, PI, & IMID

18:44
City of Hope

The Promise of Immunotherapy and Newer Agents in Multiple Myeloma

Feat. A. Krishnan
10:07
Parameswaran Hari

Multiple Myeloma - Promises and Perils of Immunotherapy

05:28
Nina Shah

Future Directions in Myeloma Post-ASCO Discussion

07:23
Indy Hematology Review

Novel Immune Therapies in Myeloma: BCMA Immunotoxin, Bites, and CAR T cells

Feat. K. Anderson
15:02
Krina Patel

Clinical Trials in Myeloma in 2018

15:47
Society of Hematologic Oncology Sixth Annual Meeting

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
12:32
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:10
Krina Patel

Developing CAR T-cells in Multiple Myeloma

13:30
Helen Heslop

CAR T-cell Therapy for Hematologic Malignancies Other Than CD19